Skip to main content
. 2020 Oct 22;11(10):892. doi: 10.1038/s41419-020-03106-4

Fig. 4. ACER2 overexpression partly reverses the effect of TIM knockdown in breast cancer cells.

Fig. 4

a, b Cell viability of MCF7 and T47D cells under the indicated treatments. Values are means ± SD, ***p < 0.001 (Student’s t-test). c, d Colony formation assay of MCF7 and T47D cells under the indicated treatments. Values are means ± SD, ***p < 0.001 (Student’s t-test). Scale bar is 5 mm. e, f The OCR of MCF7 and T47D cells under the indicated treatments (n = 3). O: Oligomycin, F: FCCP; A&R: antimycin A/rotenone. g Spare respiratory capacity of MCF7 and T47D cells under the indicated treatments. Values are means ± SD, *p < 0.05; **p < 0.01; ***p < 0.001 (Student’s t-test). h Morphologic characteristic of subcutaneous xenograft tumors from MCF7/shNC + vector-TET-on group, MCF7/shTIM+vector-TET-on group, MCF7/shTIM + oeACER2-TET-on group (n = 5). Scale bar is 10 mm. i Tumor volume at day 25 was measured in each group. Values are means ± SD, **p < 0.01 (Student’s t-test). j Tumor weight at day 25 was measured in each group. Values are means ± SD, *p < 0.05. k Representative images of Ki67 staining in xenograft from each group. Scale bar is 50 mm.